Item 1 Nature Biotechnology 22, 1105 – 1109 (2004) Published online: 31 August 2004; | doi:10.1038/nbt1009 Problems in monitoring horizontal gene transfer in field trials of transgenic plants Jack A Heinemann1, 2 & T […]
|
||||||
|
Item 1 Nature Biotechnology 22, 1105 – 1109 (2004) Published online: 31 August 2004; | doi:10.1038/nbt1009 Problems in monitoring horizontal gene transfer in field trials of transgenic plants Jack A Heinemann1, 2 & T […] Item 1 Thai cabinet overturns GMO approval 31 Aug 2004 0918:13 GMT Reuters By Trirat Puttajanyawong BANGKOK, Aug 31 (Reuters) – Thailand’s cabinet decided on Tuesday to keep a three-year ban on planting crops using ge […] ISIS Press Release 31/08/04 Pharm Crops for Vaccines and Therapeutic Antibodies Prof. Joe Cummins warns of special health impacts of vaccine and antibodies in pharm crops Reckless disregard of known risks The European Un […] Prof. Joe Cummins warns of special health impacts of vaccine and antibodies in pharm crops. […] The development of GE trees is biased against a social arrangement that rely on biological diversity. Tackling the challenge GM trees pose means tackling the industrial and bureaucratic tradition which seeks the radical simplification of landscapes. […] This report summarizes the different research emphases on transgenic woody plants, presents problems and limits of the new developments and discusses possible risks. […] Friends of the Earth comments on the environmental assessment conducted by APHIS on Permit Application No. 04-114-02r, submitted by ProdiGene, Inc. for cultivation of corn genetically engineered to produce a novel recombinant version of trypsinogen in Fri […] Item 1 For Release: August 19, 2004 For More Information: Liz Hitchcock or Richard Caplan 202-546-9707 http://www.uspirg.org/reports/dutytodisclose8_04.pdf […] Friends of the Earth comment’s on the environmental assessment conducted by APHIS on Permit Application No. 04-114-02r, submitted by ProdiGene, Inc. for cultivation of corn genetically engineered to produce a novel recombinant version of trypsinogen in F […] |
||||||
|
All our content may be republished or reused for free, except where otherwise noted. This site is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Powered by WordPress & Atahualpa |
||||||